Healthcare

Danaher (NYSE:DHR) shares fell 3.78% pre-market today to $215.55, down $8.46 from the prior close of $224.01. The decline follows third-quarter results released before the open. Adjusted EPS of $2.11 topped the $1.92 estimate by 9.90%, while sales of $6.6 billion landed in line …

Thermo Fisher Scientific (NYSE:TMO) shares fell 2.75% pre-market today to $668.50, down $18.87 from the prior close of $687.37. That close followed a 1.18% gain in the regular session and left the stock near its 12-month high of $704, as the broader sector reached …

AbbVie (NYSE:ABBV) shares traded up 2.38% to $289.42, close to a 52-week high of $291.40. The ABBV-466 Phase 2a study showed 30.2% endoscopic remission at Week 12, compared with 21.3% and 18.0% for the monotherapies, and 40.5% at Week 24.

Alvotech (NASDAQ:ALVO) shares traded up 2.49% to $5.16 after the FDA approved a new manufacturing process for Simlandi, its biosimilar to Humira. Process 2.0 is introduced in the DSM2 suite in Reykjavik and more than doubles drug substance output per batch without changing the …

argenx (NASDAQ:ARGX) shares traded up 6.29% to $877.50 as investors weighed positive Phase 3 ALKIVIA data in myositis and Phase 2 celiac results. ALKIVIA met its primary endpoint with a 15.4-point total improvement score advantage and a p-value of 0.0011.

Bristol Myers Squibb (NYSE:BMY) shares traded up 4.66% to $61.57 as a healthcare rotation lifted pharma stocks to record sector highs. Investors favored defensives amid volatility in artificial intelligence stocks and oil-driven macro jitters.

Clene (NASDAQ:CLNN) shares traded up 18.84% to $3.91 after the company said it had submitted a New Drug Application to the U.S. Food and Drug Administration. The filing, made earlier in October, seeks accelerated approval of CNM-Au8 for the treatment of amyotrophic lateral sclerosis, …